Axsome (AXSM) Posts $150M Q2 Revenue, Beats EPS Expectations
Axsome Therapeutics, Inc. (NASDAQ: AXSM) is a biopharmaceutical company headquartered in New York City that is focused on…
REGENXBIO (RGNX) Reports $89M Revenue, $6.1M Profit in Q1 2025
REGENXBIO Inc. (NASDAQ:RGNX) is a pioneering biotechnology company based in Rockville, Maryland, focused on harnessing the power of…
Avalo Therapeutics (AVTX) Surges 45% in 6 Months
Avalo Therapeutics Inc. (NASDAQ:AVTX) is a clinical-stage biotechnology company dedicated to developing transformative therapies for immune-mediated and inflammatory…
CERO Stock Price Targets $45—But Reality Sits at $6.93
CERo Therapeutics Holdings, Inc. (NASDAQ:CERO) is a clinical-stage biotechnology company based in South San Francisco, California, that is…
Long COVID Patients Report 90% Fatigue Reversal After PridCor Therapy
PridCor Therapeutics, LLC is a privately held, clinical-stage biopharmaceutical company dedicated to developing novel antiviral therapies designed to…
Oscar Health (OSCR) Revenue Hits $5.91B in First Half 2025 – Up 35.5%
Oscar Health Inc. (NYSE:OSCR) is a technology-driven health insurance company founded in 2012 with the vision of making…
Aurinia Pharmaceuticals (AUPH) Hits 52-Week High
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) is a biopharmaceutical company dedicated to advancing treatments for serious autoimmune conditions that have…
Personalis (PSNL) s Beating the Odds – And It Could Beat Cancer Too
Personalis Inc. (NASDAQ:PSNL) is a pioneering company in the field of precision oncology and advanced genomics, dedicated to…
Emergent BioSolutions (EBS) Could Keep Sinking Despite New Contracts
Emergent BioSolutions Inc. (NYSE:EBS) is a global life sciences company headquartered in Gaithersburg, Maryland, with a long-standing mission…
HealthEquity (HQY) Crushes Earnings With 67% Profit Surge
HealthEquity, Inc. (NASDAQ:HQY) is the largest independent custodian of Health Savings Accounts (HSAs) in the United States, playing…
Beam Therapeutics (BEAM) is Oversold & Ready to Explode Higher
Beam Therapeutics Inc. (NASDAQ:BEAM) is a biotechnology company at the forefront of developing precision genetic medicines through its…
TG Therapeutics (TGTX) Can Be the Next $1B Biotech Giant
TG Therapeutics Inc. (NASDAQ:TGTX) is a fully integrated biopharmaceutical company dedicated to developing and delivering transformative therapies for…
Molina Healthcare (MOH)’s Medicaid Empire Faces Its Toughest Test Yet
Molina Healthcare, Inc. (NYSE:MOH) is a Fortune 500 managed care company founded in 1980 by Dr. C. David…
Phathom Pharma (PHAT)’s Future Hangs on a Single Pill
Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) is a biopharmaceutical company headquartered in Florham Park, New Jersey, focused on the development…
Analysts Predict Over 100% Upside by 2026 for Crinetics Pharma (CRNX)
Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) is a San Diego-based clinical-stage pharmaceutical company dedicated to the discovery, development, and…
Wall Street Predicts 130%+ Upside for Serina Therapeutics (SER)
Serina Therapeutics, Inc. (NYSE:SER) is a clinical-stage biotechnology company headquartered at the HudsonAlpha Institute of Biotechnology in Huntsville,…
Aligos Therapeutics (ALGS) Doubles Cash to $122.9M
Aligos Therapeutics Inc. (NASDAQ:ALGS) is a clinical-stage biopharmaceutical company based in South San Francisco, California, that is focused…
$450M Deal With Merck Could Supercharge Neuphoria Therapeutics (NEUP)
Neuphoria Therapeutics Inc. (NASDAQ:NEUP) is a clinical-stage biotechnology company dedicated to developing innovative treatments for neuropsychiatric disorders that…